About Nicotine Gum
Nicotine gum is an over the counter, medicated chewing gum that delivers a dose of nicotine orally aiding in nicotine replacement therapy (NRT), a process for smoking cessation and quitting smokeless tobacco. Nicotine gum belongs to a class of medications called smoking cessation aids. It works by providing nicotine to the smoker’s body to reduce the withdrawal symptoms experienced when smoking is stopped and as a substitute oral activity to lessen the urge to smoke.
Attributes | Details |
---|
Study Period | 2020-2032 |
Base Year | 2024 |
Unit | Value (USD Million) |
The market for nicotine gums seems to be fragmented and with the presence of several companies, there is high competition amongst leading players. The rising enrolment in smoking cessation therapies and the increase in the number of people quitting smoking will provide substantial growth to nicotine gum manufacturers. Analyst at AMA Research estimates that United States and European Players will contribute the maximum growth to Global Nicotine Gum market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Novartis International AG (Switzerland), Johnson and Johnson (United States), GlaxoSmithKline (United Kingdom), Cambrex Corporation (United States), Perrigo (Ireland), Fertin Pharma (Denmark), Cipla (India), Glenmark Pharmaceuticals (India), Enorama Pharma (Sweden), Alchem International Pvt. Ltd. (India), Dr. Reddy’s Laboratories (India) and Teva Pharmaceutical Industries (Israel) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Nicotine Gum market by Type (Flavored {Mint, Fruit, Cinnamon, and Others} and Unflavored), Application (Hospitals, Withdrawal Clinics, Individual Smokers and Others) and Region.
On the basis of geography, the market of Nicotine Gum has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channel, the sub-segment i.e. Brick and Mortar Drug Stores will boost the Nicotine Gum market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Dosage, the sub-segment i.e. 2 mg/piece of gum will boost the Nicotine Gum market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sugar Content, the sub-segment i.e. With Added Sugar will boost the Nicotine Gum market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
An increasing number of people quitting smoking with the aid from medications like flavored nicotine gums
Market Growth Drivers:
The rise in the number of people willing to quit smoking due to increased awareness about the fatal diseases caused by smoking like lung cancer, heart attacks, and chronic obstructive pulmonary disease. and Increased government-sponsored projects and help centers worldwide for helping cigarettes addicted people quit smoking.
Challenges:
The availability of other smoking cessation products like nicotine patches, nasal sprays, inhalers, and lozenges may hinder the market penetration of nicotine gums. and Unawareness about nicotine replacement medications like nicotine gums in rural locations.
Restraints:
There are side effects associated with the long term usage of nicotine gums like narrowing of arteries, hypertension, and esophageal reflux.
Opportunities:
There is an increased opportunity for pharmaceuticals companies for the expansion of nicotine replacement products owing to the rise in the number of people seeking the help of medication. and Government nod for the purchase of nicotine gums without a prescription may further increase the market by providing prospects to many local retailers to trade nicotine gums.
Market Leaders and their expansionary development strategies
On May 21, 2019, GlaxoSmithKline launched new Nicorette Coated Ice Mint Lozenges, the first-ever coated lozenge, in partnership with the Dale Earnhardt Jr., a former American race driver an ex-smoker and In November 2017, Glenmark Pharmaceuticals launched a nicotine replacement therapy gum named Kwitz
Key Target Audience
Pharmaceutical Companies, Pharmacy Chains/Drug Stores, Drug Suppliers/Traders, Drug Exporters/Importers, Investors, Regulatory and Government Bodies, Upstream Vendors, Downstream Vendors and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.